Moffitt Site Number : 102 — Tampa, Florida

Moffitt Site Number : 102 is a clinical research site located in Tampa, Florida, United States 33612.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Moffitt Site Number : 102 has participated in 1 clinical trials.

Therapeutic areas: Chronic Graft-versus-host-disease.

Sponsors: Kadmon, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Moffitt Site Number : 102?

Moffitt Site Number : 102 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Moffitt Site Number : 102 conducted?

Moffitt Site Number : 102 has 1 clinical trials on record. Their work covers Chronic Graft-versus-host-disease.

Is Moffitt Site Number : 102 accredited by Crixeo Clinical Trials?

Moffitt Site Number : 102 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Moffitt Site Number : 102?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.